News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Sameer Hassamal, MD

Articles by Sameer Hassamal, MD

The Rise in Synthetic Cannabinoids and Cathinones

BySameer Hassamal, MD,Sunita Hassamal, MD

July 13th 2021

Cannabis has been heralded as a treatment for many conditions, but what about its psychiatric risks?

Somchaichoosiri/AdobeStock

Assessing and Addressing Synthetic Cannabinoids and Cathinones in Neuropsychiatric Toxicological Emergencies

BySameer Hassamal, MD,Sunita Hassamal, MD

January 15th 2021

Be on the lookout for these novel psychoactive substances.

Latest Updated Articles

Trending on Psychiatric Times

Lecanemab or Lithium for Alzheimer Disease Dementia? New Data Change Everything

Polypharmacy in Clozapine-Treated Patients: A Retrospective Analysis

Planned FDA Investigational New Drug Application: SPC-15 for the Treatment of PTSD

© 2025 MJH Life Sciences^®

All rights reserved.